Kindred Biosciences, Inc.
KIN
KIN was delisted on the 27th of August, 2021.
81 hedge funds and large institutions have $314M invested in Kindred Biosciences, Inc. in 2018 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 36 increasing their positions, 17 reducing their positions, and 12 closing their positions.
112% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 17
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
67% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 12
63% more call options, than puts
Call options by funds: $252K | Put options by funds: $155K
39% more capital invested
Capital invested by funds: $226M → $314M (+$88M)
11% more funds holding
Funds holding: 73 → 81 (+8)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$6.82M |
| 2 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$4.24M |
| 3 |
Allianz Asset Management
Munich,
Germany
|
+$3.4M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$2.67M |
| 5 |
SAM
Silverback Asset Management
Chapel Hill,
North Carolina
|
+$2.01M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVAM
Pacific View Asset Management
San Francisco,
California
|
-$2.73M |
| 2 |
Wells Fargo
San Francisco,
California
|
-$2.09M |
| 3 |
GAI
General American Investors
New York
|
-$1.84M |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$1.06M |
| 5 |
AFS
Amtrust Financial Services
New York
|
-$1.05M |
KIN Hedge Fund Activity: Q3 2018 in Review
81 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Kindred Biosciences, Inc. (KIN) for Q3 2018, worth a combined $314M — up 39% from $226M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new KIN positions and 12 closed out — a net gain of 8 holders — while 36 added to existing stakes and 17 trimmed.
The largest buyer was BlackRock, adding an estimated $6.82M. The largest seller was Pacific View Asset Management, cutting an estimated $2.73M.
- 81 institutional investors held Kindred Biosciences, Inc. (KIN) as of Q3 2018, up from 73 in Q2 2018.
- Funds reported $314M of Kindred Biosciences, Inc. stock for Q3 2018, up 39% quarter-over-quarter.
- 20 funds opened new Kindred Biosciences, Inc. positions in Q3 2018 and 12 closed out, a net change of +8 holders.
- The largest Kindred Biosciences, Inc. buyer in Q3 2018 was BlackRock, an estimated $6.82M added.
- The largest Kindred Biosciences, Inc. seller in Q3 2018 was Pacific View Asset Management, an estimated $2.73M sold.
Based on aggregated 13F filings for Q3 2018.